支气管肺动脉联合成形术治疗中心型非小细胞肺癌

目的 探讨支气管及肺动脉成形术的适应证、手术技术及并发症的防治。方法 回顾性分析32例行支气管肺动脉联合成形术治疗中心型非小细胞肺癌患者的临床资料。结果 并发症发生率为25．0％(8／32),术后30d死亡率6．3％(2／32),术后总的1,3,5年生存率分别为82．8％(24／29)、50．0％(11／22)和33．3％(4／12)。结论 支气管肺动脉联合成形术治疗中心型非小细胞肺癌,不仅能最大限度地保留肺组织,提高患者术后的生活质量,而且为部分肺功能差的肺癌患者提供了切除病变的机会,值得临床推广应用。

Bronchial and pulmonary arterial sleeve resection and reconstruction in the treatment of central NSCLC

Objective To evaluate the indications and surgical procedure of bronchial and pulmonary artery sleeve resection for patients with centrally loca ted non-small cell lung cancer, and how to prevent complications. Methods From July l989 to Aug 2000, 32 cases of central NSCLC were treated with bronchia l and pulmonary arterial sleeve resection and reconstruction. The results were r etrospectively analyzed. Results The complication rate was 25.0%(8/32), the mortal ity rate in 30-day postoperation was 6.3%(2/32),the overall 1-, 3- and 5-ye ar survival rate was 82.8%(24/29),50.0%(11/22)and 33.3%(4/12), respective1y . Conclusion Bronchial and pulmonary arterial sleeve resection and reconstructi on in the treatment of patients with central NSCLC can not only maximize preserv ation of functional pulmonary parenchyma and improve patients , quality of lif e, but also provide an opportunity for those patients with poor pulmonary function to receive surgical resection of the tumor.